Written by Karen Pilkington and the CAM-Cancer Consortium.
Updated February 28, 2017

Artemisia absinthium

What is it?

Description

Artemisia absinthium (Absinth(e), Wormwood, Common wormwood), Family: Asteriaceae or Compositae) is a perennial plant, which grows as a small bush with feathery leaves and pale yellow flowers.  The applicable parts are those that are above ground.1

Note: Not to be confused with Artemisia annua (Sweet wormwood).

Ingredients/Components

Wormwood’s aerial parts contain bitter principles (absinthin and anabsinthin), resins and organic acids. A volatile oil is present the composition of which has been found to vary with the largest part formed by monoterpenes. In some cases the oil contains between 10% and 90% of thujone (a monoterpene ketone) which has been linked to adverse and toxic effects.2,3 High concentrations of other monoterpenes including myrcene, and trans-sabinyl acetate have also been identified.

Application and dosage

There is no documented safe or effective dose for the use in treatment of cancer. Traditionally, wormwood has been used orally and topically. Based on traditional use, in temporary loss of appetite and mild dyspeptic/gastrointestinal disorders, a tea or tincture has been used containing the equivalent of 2-3g of the herb divided into 2 or 3 doses orally for not more than 2 weeks.4 Typical doses for other therapeutic uses are not available but the European Medicines Agency has advised that, due to potential for neurotoxicity, chemotypes with low content of thujone are preferred and the intake of thujone should not exceed 3 mg/day.4 Wormwood above ground parts have been used in flavouring alcoholic drinks but use was banned in many countries due to toxicity related to thujone. Thujone-free extracts have been used in very low concentrations in flavouring foods.1

History/providers

The plant is native to Europe, Northern Africa and Western Asia but is now found in parts of the USA and South America, although the main commercial source is Eastern Europe.2 The medical use of the wormwood plant dates back to at least Roman times and it was used as an anthelmintic (for removal of intestinal worms) and purgative, gradually becoming a general remedy for various diseases.2 Use as a ‘cure-all’ continued through to the 19th century. The adoption of wormwood-flavoured alcoholic extracts and distillates as aperitifs as well as patent medicine led to large scale production and mass use. Chronic use was linked with a syndrome known as absinthism consisting of addiction, hyperexcitability, epileptic fits and hallucination (although this has since been disputed) and this led to a decline in use.2 Interest in the plant has recently been renewed due to research in conditions such as Crohn’s disease5 and stroke6

Alleged indications

Traditional use is based on wormwood as a bitter tonic for digestive disorders and loss of appetite.4 It is promoted as a sedative and anti-inflammatory and for external use for wounds, ulcers, skin blotches and insect bites. 

Mechanisms of action

Wormwood has bactericidal, insecticidal and vermicidal activity mainly due to the thujone oils.7,8 The thujone constituent is also a central nervous system stimulant which acts by modulating gamma-aminobutyric acid (GABA) type A receptors. However, this effect is more closely linked with observed toxic effects of wormwood.2  Wormwood has been reported to reduce levels of tumour necrosis factor α (TNF-α), and may have a beneficial effect in a range of conditions influenced by pro-inflammatory cytokines such this.9,10 Crude extracts of the above ground parts of the plant have been reported to have induced anti-proliferative effects on human breast cancer cells which could possibly trigger apoptosis (programmed cell death).11  In vitro studies in breast cancer and leukaemia cell lines indicate anti-proliferative activity together with promotion of apoptosis (programmed cell death).11,12 A pilot study in leukaemia cell lines found that various plants from the Asteraceae family induced cell death by apoptosis but the correlation between polyphenol content and activity was inconsistent.12 

Prevalence of use

No data are available on the prevalence of use in cancer patients. 

Legal issues

Wormwood is classified as an unsafe drug and banned in many countries including the USA although "thujone-free" wormwood extract has been approved by the US Food and Drug Administration (FDA) for use in foods and as a flavouring in alcoholic drinks.13 In Europe, Artemisia absinthium L. has been recognised by the European Medicines Agency as a herb for which use is based on traditional use.4 

Costs and expenditures

Wormwood products are available on the internet, most commonly in the form of tincture (1:3 Alcohol Volume 45%). Based on the suggested doses, the cost of one month’s treatment would be between 7 and 36 Euros.

Citation

Karen Pilkington, CAM-Cancer Consortium. Artemisia absinthium [online document]. http://cam-cancer.org/The-Summaries/Herbal-products/Artemisia-absinthium. February 28, 2017.

Document history

Assessed as up to date in February 2017 by Barbara Wider.
Assessed as up to date in January 2015 by Barbara Wider.
First published in May 2014 authored by Karen Pilkington.

References

  1. Natural Medicines Comprehensive Database. Absinthium (wormwood). Available at  http://naturaldatabase.therapeuticresearch.com, accessed 28th February 2017.
  2. Lachenmeier DW. Wormwood (Artemisia absinthium L.)--a curious plant with both neurotoxic and neuroprotective properties? J Ethnopharmacol. 2010 Aug 19;131(1):224-7.
  3. Judþentienë A, Mockutë D. Chemical composition of essential oils of Artemisia absinthium L. (wormwood) growing wild in Vilnius. CHEMIJA. 2004. T. 15. Nr. 4. P. 64–68.
  4. Committee on Herbal Medicinal Products. EMEA/HMPC/234463/2008: Community Herbal Monograph on Artemisia Absinthium L., Herba. European Medicines Agency 2009.
  5. Krebs S, Omer TN, Omer B. Wormwood (Artemisia absinthium) suppresses tumour necrosis factor alpha and accelerates healing in patients with Crohn's disease - A controlled clinical trial. Phytomedicine. 2010 Apr;17(5):305-9.
  6. Bora KS, Sharma A. Neuroprotective effect of Artemisia absinthium L. on focal ischemia and reperfusion-induced cerebral injury.  J Ethnopharmacol. 2010 Jun 16;129(3):403-9.
  7. Blagojevic P , Radulovic N , Palic R , Stojanovic G . Chemical composition of the essential oils of Serbian wild-growing Artemisia absinthium and Artemisia vulgaris. J Agric Food Chem . 2006 ; 54 (13); 4780-4789
  8. Lopes-Lutz D, Alviano DS, Alviano CS, Kolodziejczyk PP. Screening of chemical composition, antimicrobial and antioxidant activities of Artemisia essential oils. Phytochemistry. 2008 May;69(8):1732-8.
  9. Krebs S, Omer TN, Omer B. Wormwood (Artemisia absinthium) suppresses tumour necrosis factor alpha and accelerates healing in patients with Crohn's disease - A controlled clinical trial. Phytomedicine. 2010 Apr;17(5):305-9.
  10. Krebs S, Omer B, Omer TN, Fliser D. Wormwood (Artemisia absinthium) for poorly responsive early-stage IgA nephropathy: a pilot uncontrolled trial. Am J Kidney Dis. 2010 Dec;56(6):1095-9.
  11. Shafi G, Hasan TN, Syed NA, Al-Hazzani AA, Alshatwi AA, Jyothi A, Munshi A. Artemisia absinthium (AA): a novel potential complementary and alternative medicine for breast cancer. Mol Biol Rep. 2012 Jul;39(7):7373-9.
  12. Wegiera M, Smolarz HD, Jedruch M, Korczak M, Koproń K. Cytotoxic effect of some medicinal plants from Asteraceae family on J-45.01 leukemic cell line--pilot study. Acta Pol Pharm. 2012 Mar-Apr;69(2):263-8.
  13. Food and Drug Administration. Dietary Supplements. Available at: https://www.fda.gov/Food/DietarySupplements/default.htm, accessed 28th February 2017. 
  14. Lachenmeier DW, Walch SG, Padosch SA, Kröner LU. Absinthe--a review. Crit Rev Food Sci Nutr. 2006;46(5):365-77.
  15. Weisbord, M.D., Jeremy B. Soule, M.D., and Paul L. Kimmel, M.D. Poison on Line — Acute Renal Failure Caused by Oil of Wormwood Purchased through the Internet. N Engl J Med 1997; 337:825-827
  16. Pelkonen O, Abass K, Wiesner J. Thujone and thujone-containing herbal medicinal and botanical products: toxicological assessment. Regul Toxicol Pharmacol. 2013 Feb;65(1):100-7.
  17. Açıkgöz SK, Açıkgöz E. Gastrointestinal bleeding secondary to interaction of Artemisia absinthium with warfarin. Drug Metabol Drug Interact. 2013;28(3):187-9.